Prokidney (PROK) EPS (Weighted Average and Diluted) (2021 - 2026)
Prokidney (PROK) reported EPS (Weighted Average and Diluted) of -$0.14 for Q1 2026, down 7.69% year-over-year from -$0.15 in Q1 2025, and little changed quarter-over-quarter from -$0.14 in Q4 2025.
Prokidney (PROK) EPS (Weighted Average and Diluted) (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.14 in Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.14, down 7.69% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.53 (up 11.67% YoY), and the FY2025 annual result was -$0.52, up 16.13% from the prior year.
- EPS (Weighted Average and Diluted) was little changed at -$0.14 in Q1 2026 per PROK's latest filing, from -$0.14 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at -$0.07 in Q2 2022 and troughed at -$0.23 in Q4 2022.
- A 5-year average of -$0.14 and a median of -$0.14 in 2023 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2022 and 2023: EPS (Weighted Average and Diluted) sank 7130.05% in 2022, then soared 60.87% in 2023.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.23 in 2022, then soared by 60.87% to -$0.09 in 2023, then sank by 88.89% to -$0.17 in 2024, then rose by 17.65% to -$0.14 in 2025, then changed by 0.0% to -$0.14 in 2026.
- Business Quant data shows PROK's EPS (Weighted Average and Diluted) at -$0.14 in Q1 2026, -$0.14 in Q4 2025, and -$0.12 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | Prokidney | 259.01 Mn | 1.55 Bn | - | -0.14 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.14 |
| Dec 31, 2025 | -0.14 |
| Sep 30, 2025 | -0.12 |
| Jun 30, 2025 | -0.13 |
| Mar 31, 2025 | -0.13 |
| Dec 31, 2024 | -0.17 |
| Sep 30, 2024 | -0.14 |
| Jun 30, 2024 | -0.16 |
| Mar 31, 2024 | -0.16 |
| Dec 31, 2023 | -0.09 |
| Sep 30, 2023 | -0.18 |
| Jun 30, 2023 | -0.14 |
| Mar 31, 2023 | -0.16 |
| Dec 31, 2022 | -0.23 |
| Sep 30, 2022 | -0.13 |
| Jun 30, 2022 | -0.07 |
| Jun 30, 2021 | 0.00 |